Screening methods using B7-H2 molecules, members of the B7...

Details Screening methods using B7-H2 molecules, members of the B7... Screening methods using B7-H2 molecules, members of the B7...

2003-08-20

2008-10-07

Ouspenski, Ilia (Department: 1644)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

Reexamination Certificate

active

07432062

ABSTRACT:
Novel B7-like polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length B7-like proteins, the invention further provides isolated B7-like fusion proteins, antigenic peptides, and anti-B7-like antibodies. The invention also provides B7-like nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a B7-like gene has been introduced or disrupted. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided.

REFERENCES:
patent: 5521288 (1996-05-01), Linsley et al.
patent: 5861310 (1999-01-01), Freeman et al.
patent: 5942607 (1999-08-01), Freeman et al.
patent: 5968510 (1999-10-01), Linsley et al.
patent: 6812339 (2004-11-01), Venter et al.
patent: 2002/0095024 (2002-07-01), Mikesell et al.
patent: 2002/0106730 (2002-08-01), Coyle et al.
patent: 2002/0164600 (2002-11-01), Freeman et al.
patent: 1074617 (2001-02-01), None
patent: WO 95/03408 (1995-02-01), None
patent: WO 95/05464 (1995-02-01), None
patent: WO 96/40915 (1996-12-01), None
patent: WO 97/24447 (1997-07-01), None
patent: WO 00/37643 (2000-06-01), None
patent: WO 00/61612 (2000-10-01), None
patent: WO 01/34629 (2001-05-01), None
patent: WO 01/49716 (2001-07-01), None
patent: WO 00/55375 (2001-09-01), None
patent: WO 01/83750 (2001-11-01), None
patent: WO 01/94413 (2001-12-01), None
Attwood, Science 2000; 290:471-473.
Metzler et al., Nature Structural Biol. 1997; 4:527-531.
Greenwald et al., 2005, Annu. Rev. Immunol., 23: 515-548.
Database EMBL Sequence Database [Online]Hinxton, UK; Jun. 1, 1999 S. Y. Tseng et al.: “Mus Musculus Butyrophilin-like (Btdc) mRNA, Complete cds.” EMBL Sequence Accession No. AF142780.
Database EMBL Sequence Database [Online]Hinxton, UK; Feb. 22, 2000 T. Isogai and T. Otsuki:Homo sapienscDNA FLJ11010 fis, clone PLACE1003145; XP002193892. EMBL Sequence Accession No. AK001872.
Gerstmayer, et al., Cancer Immunology Immunotherapy 45(3-4): 156-158 (1997).
Schwartz, et al., Nat. Immunol. 3(5):427-434 (2002).
Inobe et al., J. Immunol. 157:582-588 (1996).
Abbas et al.,Nature Medicine 5(12) :1345-1346 (1999).
Dong et al.,Nature Medicine 5(12) :1365-1369 (1999).
Fargeas et al.,J. Exp. Med.182:667-675 (1995).
Freeman et al.,The FASEB Journal 14(6) :Abstract 153.34, p. A1170 (2000).
Hutloff et al.,Nature 397:263-266 (1999).
Ling et al.,J. Immunol.164(4):1653-1657 (2000).
Mages et al.,Eur. J. Immunol.30 (4) :1040-1047 (2000).
Peach et al.,Journal of Biological Chemistry 270(36) :21181-21187 (1995).
Yoshinaga et al.,Nature 402(6763) 827-832 (1999).

Affiliated with

Also associated with

Rating

Screening methods using B7-H2 molecules, members of the B7... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Screening methods using B7-H2 molecules, members of the B7..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening methods using B7-H2 molecules, members of the B7... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4006066